Balancing Oracle’s Backlog Against Its Balance Sheet
Oracle is sitting on a record AI backlog that analysts say could justify nearly doubling the stock price, yet the company just posted negative free cash flow and its CFO cannot say when that changes. Something has to give.
Oracle (NYSE:ORCL | ORCL Price Prediction) trades at $126.08. Its record AI backlog and its debt-funded expansion are drawing the stock in opposite directions. Shares were recently caught up in a broader AI debt selloff.
Oracle sells databases and enterprise applications, and it now runs one of the fastest-growing AI cloud businesses. Cloud revenue reached $11.61B last quarter, up 62%, and now makes up 60% of total revenue. Paying for that growth drove quarterly capex to $28.5B and free cash flow to negative $5.4B. The stock is down 34.41% year to date.
A $664 Billion Backlog Priced at 18 Times Forward Earnings
Remaining performance obligations total $664B, up $209B year over year. Management expects “around half of our RPO to convert into sales over the next 36 months.” Customers signed more than $30 billion in new AI contracts, and most were structured as prepayments or bring-your-own-hardware deals. Cloud infrastructure revenue increased 121%. GPU use hit 97.9%, and renewals were priced at a 20% premium.
Operating leverage is showing up. Operating income rose 57.3% on 29.6% revenue growth. Guidance calls for at least $90B in fiscal 2027 revenue and $8.10 in non-GAAP EPS. Over the past 30 days, 35 analysts raised full-year estimates and only 1 cut them. A forward P/E of 18 and a PEG of 0.802 look cheap for that growth rate.
Interest Costs and Dilution Threaten Shareholder Returns
Free cash flow was negative $23.7B in fiscal 2026. Quarterly interest expense rose 55% to $1.43B. Total debt stands at $155.9B, and capital lease obligations add $30.6B. Oracle just finished a $20B at-the-market equity sale and plans to raise about $40B this fiscal year through debt and equity. Asked when free cash flow turns positive, CFO Hilary Maxson said, “We haven’t given a particular timeframe on that yet.”
A handful of very large AI contracts make up much of the backlog, and license revenue fell 15%. DA Davidson’s Gil Luria named data center execution and a leveraged balance sheet as the two biggest constraints. The market also punishes misses. Shares fell about 13% after a revenue miss last December.
Execution Is Strong, but Cash Flow Proof Is Still Missing
Execution has been strong. Oracle delivered 850MW of capacity and generated record operating cash flow of $23.1B. Funding remains unclear. Net cash capex could reach $70 billion this year, and management has given no date for positive free cash flow.
Oracle itself is the expansion story here, but it isn’t building alone. The companies that equip these data centers — providing electricity, cooling and network infrastructure — make up a trade of their own, and we covered seven of them in a free report: 7 Stocks Powering the AI Boom (That Aren’t Chipmakers).
The next earnings report tests cloud growth guidance of 65-71% and EPS guidance of $1.85-$1.93. Investors should also watch borrowing terms and progress at the New Mexico and Wisconsin sites.
Analysts See 87.6% Upside as the Stock Lags the S&P 500
The consensus target at $236.54 suggests a 87.6% gain from $126.08. Targets are only one data point. 43 analysts cover the stock:
- Strong Buy: 7
- Buy: 28
- Hold: 7
- Sell: 1
Oracle trades at 20 times trailing earnings and has a beta of 1.77. Over the past year, shares fell 54.35% while the S&P 500 rose 13.13%. Over the past month, Oracle dropped 12.42%, and the index slipped 1.02%.
Free Cash Flow Is the Missing Piece for Oracle
At $126.08, Oracle’s risks and rewards look balanced.
The backlog is real, and revenue from it is starting to show up. Yet the balance sheet takes on each new contract before shareholders see the cash. A stronger outlook needs two things: a clear date for positive free cash flow, and proof that customer prepayments are reducing outside funding needs. A weaker outlook would follow a revenue miss, slower cloud growth or expensive new debt.
Upside could arrive quickly. A turn in free cash flow could rerate the stock quickly at 18 times forward earnings. Dilution remains a risk, because more equity issue would dilute current holders. Each quarter, check RPO conversion, net capex and interest expense.
Oracle’s backlog makes the business more valuable, but until the funding gap closes, the funding gap remains the key variable for the stock.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
